Get access

Commentary on ‘Glucocorticoids for the treatment of anaphylaxis’

Authors

  • Alexandra F. Santos,

    Corresponding author
    1. Department of Pediatric Allergy, Division of Asthma, Allergy & Lung Biology, King's College London-MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK
    2. Immunoallergology Department, Coimbra University Hospital, Coimbra, Portugal
    3. Gulbenkian Programme for Advanced Medical Education, Lisbon, Portugal
    • Department of Pediatric Allergy, Division of Asthma, Allergy and Lung Biology, King's College London, 5th floor Tower Wing, Guy's Hospital, London SE1 9RT, UK.
    Search for more papers by this author
  • Gideon Lack

    1. Department of Pediatric Allergy, Division of Asthma, Allergy & Lung Biology, King's College London-MRC & Asthma UK Centre in Allergic Mechanisms of Asthma, London, UK
    Search for more papers by this author

Abstract

This is a commentary on a Cochrane review, published in the issue of EBCH, first published as: Choo KJL, Simons FER, Sheikh A. Glucocorticoids for the treatment of anaphylaxis. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD007596. DOI: 10.1002/14651858.CD007596.pub3.

Ancillary